Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Neoplasms × Ultrasonography × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Thoracic Neoplasms 1 Sarcopenia 1 Renal Colic 1 Pregnancy, Ectopic 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Mesothelioma 1 Cysts 1 Cholecystitis 1 Abortion, Spontaneous 1

Interventions

Carboplatin 12 Pemetrexed 6 pembrolizumab 5 Paclitaxel 5 osimertinib 4 atezolizumab 4 entinostat 3 durvalumab 3 Erlotinib Hydrochloride 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Radiosurgery 2 Injections 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 taletrectinib 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 exemestane 1 efineptakin alfa 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡